PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 116 filers reported holding PROVENTION BIO INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $617,418 | +481.3% | 25,619 | +155.0% | 0.00% | – |
| Q4 2022 | $106,207 | +658.6% | 10,048 | +225.3% | 0.00% | – |
| Q3 2022 | $14,000 | -41.7% | 3,089 | -50.2% | 0.00% | – |
| Q2 2022 | $24,000 | -71.4% | 6,209 | -45.7% | 0.00% | – |
| Q1 2022 | $84,000 | -19.2% | 11,445 | -38.0% | 0.00% | – |
| Q4 2021 | $104,000 | -69.2% | 18,453 | -65.0% | 0.00% | – |
| Q3 2021 | $338,000 | +118.1% | 52,768 | +187.2% | 0.00% | – |
| Q2 2021 | $155,000 | +49.0% | 18,374 | +86.2% | 0.00% | – |
| Q1 2021 | $104,000 | -58.2% | 9,870 | -32.9% | 0.00% | – |
| Q4 2020 | $249,000 | +130.6% | 14,716 | +74.6% | 0.00% | – |
| Q3 2020 | $108,000 | -98.7% | 8,428 | -98.5% | 0.00% | -100.0% |
| Q2 2020 | $8,188,000 | +6723.3% | 580,322 | +4346.6% | 0.01% | – |
| Q1 2020 | $120,000 | +122.2% | 13,051 | +258.2% | 0.00% | – |
| Q4 2019 | $54,000 | – | 3,643 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |